AOPEP and Alzheimer disease: On the other hand, as recently described, lipid, including triglycerides, variations in response to statins may be inherited and pharmacogenetically mediated in AD [46], therefore the genetic background (in particular APO E polymorphism), not available in our study, may have influenced the lack of association between TyG index and AD diagnosis.